| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |